| Robotic Surgery |
0 |
1 |
| Breast Cancer |
0 |
0.9 |
| Otolaryngology |
0 |
0.85 |
| Prostate Cancer |
0 |
0.77 |
| Surgery |
0 |
0.99 |
| Aesthetic Medicine |
0 |
0.64 |
| Laparoscopic Surgery |
0 |
0.58 |
| Colorectal Surgery |
0 |
0.54 |
| Head and Neck Surgery |
0 |
0.46 |
| Renal Cell Carcinoma |
0 |
0.39 |
| Cancer |
0 |
0.34 |
| Robotic Radical Prostatectomy |
0 |
0.98 |
| Kidney Cancer |
0 |
0.28 |
| Biologic Therapy |
0 |
0.27 |
| Cervical Cancer |
0 |
0.27 |
| Acute Pain |
0 |
0.25 |
| Bladder Cancer |
0 |
0.25 |
| Cancer Pain |
0 |
0.21 |
| Prostate |
0 |
0.16 |
| Prostate Specific Antigen |
0 |
0.16 |
| Fibroma |
0 |
0.13 |
| Tumor |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.1 |
| Partial Nephrectomy |
0 |
0.1 |
| Radical Hysterectomy |
0 |
0.09 |
| Radical Prostatectomy |
0 |
0.09 |
| Abdomen |
0 |
0.08 |
| Hysterectomy |
0 |
0.08 |
| Incision |
0 |
0.08 |
| Mastectomy |
0 |
0.08 |
| Prostatectomy |
0 |
0.08 |
| Tissue |
0 |
0.08 |
| Uterine Leiomyoma |
0 |
0.06 |
| Clinical Research |
0 |
0.05 |
| Cosmetic Dermatology |
0 |
0.05 |
| Cosmetics |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Pain Management |
0 |
0.05 |
| Radical Cystectomy |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.96 |
| Airway |
0 |
0.03 |
| Antigens |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Bone |
0 |
0.03 |
| Breast |
0 |
0.03 |
| California |
0 |
0.03 |
| Cervical Region |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Clinician Health and Well-Being |
0 |
0.03 |
| Cystectomy |
0 |
0.03 |
| Hemorrhage |
0 |
0.03 |
| Kentucky |
0 |
0.03 |
| Kidney |
0 |
0.03 |
| Kidney, Ureter, and Bladder |
0 |
0.03 |
| Medical Life |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| New York |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Perioperative Care |
0 |
0.03 |
| Pneumoperitoneum |
0 |
0.03 |
| Postoperative |
0 |
0.03 |
| Resection |
0 |
0.03 |
| Scar |
0 |
0.03 |
| Supernumerary Nipple |
0 |
0.03 |
| Triage |
0 |
0.03 |
| Uterus |
0 |
0.03 |